Form 4: Illumina SVP, Chief Technology Officer Steven Barnard Reports Changes in Beneficial Ownership

Steven Barnard, SVP and Chief Technology Officer of Illumina, reports acquisition of restricted stock units and performance shares, along with shares acquired through the Employee Stock Purchase Plan.

Summary

• On March 5, 2024, Steven Barnard, SVP, Chief Technology Officer of Illumina, reported changes in beneficial ownership.
• Barnard acquired 5,792 shares of common stock at $0 and 6,757 performance shares tied to the company's three-year average operating margin for fiscal years 2024-2026, vesting on January 3, 2027.
• He also acquired 6,757 performance shares linked to Illumina's relative total shareholder return for the fiscal year ending January 3, 2027.
• The number of shares issued for both performance stock units will range from 0% to 200% based on performance against pre-defined objectives.
• The report also indicates that Barnard beneficially owns 27,581 shares, which includes 132 shares acquired through the Employee Stock Purchase Plan.
• The restricted stock units vest 25% annually on February 15 from 2025 to 2028.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices and aligns management incentives with company performance.

Positives

• The acquisition of performance shares aligns the executive's interests with the company's long-term performance, specifically operating margin and shareholder return.
• The vesting schedule of the restricted stock units encourages continued service with the company.

Risks

• The actual number of performance shares issued depends on Illumina's performance against pre-defined objectives, introducing uncertainty.
• The executive must remain a service provider to receive the vesting shares.

Future Outlook

The number of performance shares ultimately issued will depend on Illumina's performance relative to pre-defined objectives for operating margin and total shareholder return over the specified periods.

Industry Context

Executive compensation packages often include performance-based equity awards to align management's interests with those of shareholders. This filing reflects a standard practice in the industry.

Comparison to Industry Standards

• Companies like Thermo Fisher Scientific and Danaher also use performance-based equity compensation for their executives.
• The vesting schedules and performance metrics used by Illumina are typical for companies in the life sciences and diagnostics industries.
• The range of 0% to 200% payout for performance shares is a common structure to incentivize significant outperformance.

Stakeholder Impact

• Shareholders: The performance-based equity awards aim to align management's interests with shareholder value creation.
• Employees: The Employee Stock Purchase Plan provides employees with the opportunity to acquire company stock.

Key Dates